MRNA LIGHTNING Trademark

Trademark Overview


On Wednesday, May 25, 2022, a trademark application was filed for MRNA LIGHTNING with the United States Patent and Trademark Office. The USPTO has given the MRNA LIGHTNING trademark a serial number of 79347337. The federal status of this trademark filing is REGISTERED as of Tuesday, June 4, 2024. This trademark is owned by Anima Biotech Inc.. The MRNA LIGHTNING trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceuticals, namely, small molecule therapeutic preparations for the regulation of mRNA translation and mRNA biology, used in the treatment of fibrosis, cancers, neurological diseases, infectious diseases, genetic diseases, and other diseases

Research, analysis, and development of pharmaceuticals, namely, small molecule therapeutic preparations for the regulation of mRNA translation and mRNA biology, used in the treatment of fibrosis, cancers, neurological diseases, infectious diseases, genetic diseases, and other diseases
mrna lightning

General Information


Serial Number79347337
Word MarkMRNA LIGHTNING
Filing DateWednesday, May 25, 2022
Status700 - REGISTERED
Status DateTuesday, June 4, 2024
Registration Number7403950
Registration DateTuesday, June 4, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 19, 2024

Trademark Statements


Goods and ServicesPharmaceuticals, namely, small molecule therapeutic preparations for the regulation of mRNA translation and mRNA biology, used in the treatment of fibrosis, cancers, neurological diseases, infectious diseases, genetic diseases, and other diseases
NOT AVAILABLE"MRNA"
Goods and ServicesResearch, analysis, and development of pharmaceuticals, namely, small molecule therapeutic preparations for the regulation of mRNA translation and mRNA biology, used in the treatment of fibrosis, cancers, neurological diseases, infectious diseases, genetic diseases, and other diseases

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, August 12, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, August 12, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAnima Biotech Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressUS

Party NameAnima Biotech Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressUS

Party NameAnima Biotech Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressUS

Trademark Events


Event DateEvent Description
Friday, August 12, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, August 11, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB
Tuesday, August 16, 2022APPLICATION FILING RECEIPT MAILED
Saturday, March 4, 2023NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, March 14, 2023ASSIGNED TO EXAMINER
Wednesday, March 15, 2023NON-FINAL ACTION WRITTEN
Thursday, March 16, 2023NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, May 4, 2023REFUSAL PROCESSED BY MPU
Thursday, May 4, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, May 24, 2023REFUSAL PROCESSED BY IB
Monday, June 26, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, June 26, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, June 27, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, August 30, 2023NON-FINAL ACTION WRITTEN
Wednesday, August 30, 2023NON-FINAL ACTION E-MAILED
Wednesday, August 30, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, September 5, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, October 4, 2023REFUSAL PROCESSED BY IB
Wednesday, January 17, 2024NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Wednesday, January 17, 2024NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Tuesday, January 23, 2024ASSIGNED TO LIE
Wednesday, January 24, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, January 24, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, February 5, 2024NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Tuesday, March 19, 2024PUBLISHED FOR OPPOSITION
Tuesday, March 19, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Saturday, February 10, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 28, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, February 28, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 4, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Wednesday, September 4, 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, June 4, 2024REGISTERED-PRINCIPAL REGISTER